Your browser doesn't support javascript.
loading
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.
Weigelt, Britta; Comino-Méndez, Iñaki; de Bruijn, Ino; Tian, Lei; Meisel, Jane L; García-Murillas, Isaac; Fribbens, Charlotte; Cutts, Ros; Martelotto, Luciano G; Ng, Charlotte K Y; Lim, Raymond S; Selenica, Pier; Piscuoglio, Salvatore; Aghajanian, Carol; Norton, Larry; Murali, Rajmohan; Hyman, David M; Borsu, Laetitia; Arcila, Maria E; Konner, Jason; Reis-Filho, Jorge S; Greenberg, Roger A; Robson, Mark E; Turner, Nicholas C.
Afiliación
  • Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. weigeltb@mskcc.org nicholas.turner@icr.ac.uk.
  • Comino-Méndez I; Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom.
  • de Bruijn I; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Tian L; Department of Cancer Biology, Basser Center for BRCA, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Meisel JL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • García-Murillas I; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.
  • Fribbens C; Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom.
  • Cutts R; Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom.
  • Martelotto LG; Breast Unit, The Royal Marsden Hospital, Fulham Road, London, United Kingdom.
  • Ng CKY; Breast Cancer Now Research Centre, Institute of Cancer Research, London, United Kingdom.
  • Lim RS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Selenica P; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Piscuoglio S; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Aghajanian C; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Norton L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Murali R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hyman DM; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Borsu L; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Arcila ME; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Konner J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Greenberg RA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Robson ME; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Turner NC; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Clin Cancer Res ; 23(21): 6708-6720, 2017 Nov 01.
Article en En | MEDLINE | ID: mdl-28765325

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama / Proteína BRCA1 / Proteína BRCA2 / Ácidos Nucleicos Libres de Células Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama / Proteína BRCA1 / Proteína BRCA2 / Ácidos Nucleicos Libres de Células Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article